Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant. [electronic resource]
- Nucleic acid therapeutics Feb 2016
- 1-9 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
2159-3345
10.1089/nat.2015.0565 doi
Anticoagulants--pharmacology Antidotes--pharmacology Aptamers, Nucleotide--chemistry Base Sequence Blood Coagulation Factors--genetics Humans Molecular Sequence Data Nucleic Acid Conformation Serine Proteases--genetics